Literature DB >> 19555584

NCCN clinical practice guidelines in oncology: kidney cancer.

Robert J Motzer1, Neeraj Agarwal, Clair Beard, Graeme B Bolger, Barry Boston, Michael A Carducci, Toni K Choueiri, Robert A Figlin, Mayer Fishman, Steven L Hancock, Gary R Hudes, Eric Jonasch, Anne Kessinger, Timothy M Kuzel, Paul H Lange, Ellis G Levine, Kim A Margolin, M Dror Michaelson, Thomas Olencki, Roberto Pili, Bruce G Redman, Cary N Robertson, Lawrence H Schwartz, Joel Sheinfeld, Jue Wang.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19555584     DOI： 10.6004/jnccn.2009.0043

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  79 in total

1.  Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

Authors:  Andrew Feifer; Caroline Savage; Heidi Rayala; William Lowrance; Geoffrey Gotto; Preston Sprenkle; Amit Gupta; Jennifer Taylor; Melanie Bernstein; Adebowale Adeniran; Satish K Tickoo; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

Review 2.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

Review 3.  Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy.

Authors:  E Jason Abel; Christopher G Wood
Journal:  Nat Rev Urol       Date:  2009-06-16       Impact factor: 14.432

4.  Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

Authors:  Milind Javle; Maeve Lowery; Rachna T Shroff; Karl Heinz Weiss; Christoph Springfeld; Mitesh J Borad; Ramesh K Ramanathan; Lipika Goyal; Saeed Sadeghi; Teresa Macarulla; Anthony El-Khoueiry; Robin Kate Kelley; Ivan Borbath; Su Pin Choo; Do-Youn Oh; Philip A Philip; Li-Tzong Chen; Thanyanan Reungwetwattana; Eric Van Cutsem; Kun-Huei Yeh; Kristen Ciombor; Richard S Finn; Anuradha Patel; Suman Sen; Dale Porter; Randi Isaacs; Andrew X Zhu; Ghassan K Abou-Alfa; Tanios Bekaii-Saab
Journal:  J Clin Oncol       Date:  2017-11-28       Impact factor: 44.544

5.  Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.

Authors:  Saby George; Robert J Motzer; Hans J Hammers; Bruce G Redman; Timothy M Kuzel; Scott S Tykodi; Elizabeth R Plimack; Joel Jiang; Ian M Waxman; Brian I Rini
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

Review 6.  Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies.

Authors:  Aaron A Laviana; Jim C Hu
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

7.  Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials.

Authors:  Laeeq Malik; Helen Parsons; Devalingam Mahalingam; Benjamin Ehler; Martin Goros; Alex Mejia; Andrew Brenner; John Sarantopoulos
Journal:  Clin Genitourin Cancer       Date:  2014-02-04       Impact factor: 2.872

8.  Induction of cold ischemia in patients with solitary kidney using retrograde intrarenal cooling: 2-year functional outcomes.

Authors:  Theodore R Saitz; Philip J Dorsey; Jan Colli; Benjamin R Lee
Journal:  Int Urol Nephrol       Date:  2013-02-06       Impact factor: 2.370

9.  Utilization of renal mass biopsy in patients with renal cell carcinoma.

Authors:  John T Leppert; Janet Hanley; Todd H Wagner; Benjamin I Chung; Sandy Srinivas; Glenn M Chertow; James D Brooks; Christopher S Saigal
Journal:  Urology       Date:  2014-02-12       Impact factor: 2.649

10.  Recent advances in management of renal cancer.

Authors:  Jay H Shah; David M Nanus
Journal:  F1000 Med Rep       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.